Investor profile
Mission BioCapital
Life-sciences venture firm. An early investor in Cereius, the Durham Duke spinout Solve Therapeutics acquired in 2023, per general partner Eric Linsley.
Venture fund
Directory portfolio
Companies connected here
0
Portfolio connections are still being added to this profile.
Portfolio coverage reflects public company-investor links tracked in this directory and may not represent the investor's full portfolio.